Press Releases Archives

Press Releases

Psychemedics Test for Fentanyl Detection Cleared by FDA

April 25, 2019

Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, MA, April 24, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse…

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

April 25, 2019

Psychemedics

Press Releases

Acton, MA, April 23, 2019 — Psychemedics Corporation (NASDAQ:PMD) today announced first-quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18…

New Psychemedics Offering Further Enhances Cocaine Detection

March 27, 2019

admin

Press Releases

Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader in detecting drugs of…

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

September 26, 2017

Psychemedics

Press Releases

In another first, the world’s largest hair drug testing company & scientific leader launches new test for Benzodiazepines Acton, Massachusetts, September 26, 2017 – Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer…

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

August 22, 2017

Psychemedics

Press Releases, Uncategorized

World’s largest hair drug testing company & scientific leader launches new tool for combatting rising Synthetic Cannabinoids (K2, Spice) abuse Acton, Massachusetts, August 22, 2017– Psychemedics Corporation (NASDAQ:PMD), hair testing…

Psychemedics Corporation – First Lab Approved For Hair Testing in Iowa

August 22, 2017

Psychemedics

Press Releases

Acton, MA, August 16, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced it has become the first laboratory to be approved for the testing of drugs of abuse in hair by…

Psychemedics Corporation Announces 2017 Q2 Earnings

August 2, 2017

Psychemedics

Press Releases

Psychemedics 2017 Q2 Earnings ACTON, Mass., Aug. 2, 2017 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2017. The Company…

Psychemedics Corporation Responds To Recent Price Volatility

January 31, 2017

Psychemedics

Press Releases, Uncategorized

Acton, Massachusetts, January 31, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced that recent volatility in its stock price on January 31, 2017 appears to have been caused by a news…

Trucking Alliance Companies Petition USDOT to Close Drug Test Loophole

November 7, 2016

admin

Press Releases

NEWS RELEASE October 27, 2016 Trucking Alliance Asks FMSCA To Allow Hair Drug Testing October 28th, 2016 Washington, D.C. Transportation companies affiliated with The Alliance for Driver Safety & Security…

Psychemedics Corporation Earns Prestigious Recognition for Superior Customer Service

September 15, 2016

Psychemedics

Press Releases

Award-Winning Customer Support Team is now a “Certified Center of Excellence” ACTON, Mass., Sept. 13, 2016 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD), the world’s leading and largest hair analysis drug testing…

Press Releases

Psychemedics Test for Fentanyl Detection Cleared by FDA

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

New Psychemedics Offering Further Enhances Cocaine Detection

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

Psychemedics Corporation – First Lab Approved For Hair Testing in Iowa

Psychemedics Corporation Announces 2017 Q2 Earnings

Psychemedics Corporation Responds To Recent Price Volatility

Trucking Alliance Companies Petition USDOT to Close Drug Test Loophole

Psychemedics Corporation Earns Prestigious Recognition for Superior Customer Service

Recent Posts

Categories

Archives